Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for ARDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 426.88M
March 31, 2026 355.88M
December 31, 2025 335.86M
September 30, 2025 331.89M
June 30, 2025 327.24M
March 31, 2025 264.52M
December 31, 2024 262.46M
September 30, 2024 209.57M
June 30, 2024 196.50M
March 31, 2024 191.49M
December 31, 2023 130.76M
September 30, 2023 98.22M
June 30, 2023 88.04M
March 31, 2023 91.60M
December 31, 2022 91.74M
September 30, 2022 77.81M
June 30, 2022 78.57M
March 31, 2022 65.22M
December 31, 2021 67.30M
September 30, 2021 89.42M
June 30, 2021 87.41M
March 31, 2021 79.48M
December 31, 2020 75.45M
September 30, 2020 67.22M
June 30, 2020 70.99M
Date Value
March 31, 2020 67.56M
December 31, 2019 73.13M
September 30, 2019 70.25M
June 30, 2019 69.36M
March 31, 2019 74.29M
December 31, 2018 67.52M
September 30, 2018 65.22M
June 30, 2018 65.12M
March 31, 2018 13.86M
December 31, 2017 18.59M
September 30, 2017 16.47M
June 30, 2017 19.14M
March 31, 2017 20.08M
December 31, 2016 19.98M
September 30, 2016 18.42M
June 30, 2016 14.77M
March 31, 2016 12.75M
December 31, 2015 8.045M
September 30, 2015 12.94M
June 30, 2015 5.928M
March 31, 2015 47.40M
December 31, 2014 52.73M
September 30, 2014 54.43M
June 30, 2014 60.61M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
REGENXBIO, Inc. 314.85M
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B
Anika Therapeutics, Inc. 46.19M
Savara, Inc. 48.48M

Total Liabilities (Quarterly) Related Metrics